CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
These are the types of companies that are still in their early growth stages and that can possess significant upside. There is some unavoidable risk and uncertainty, and the key is to ensure you don't take on too much. One stock that's been on my watch list for a while is CRISPR Therapeutics (NASDAQ: CRSP) . The company has an intriguing business, as not only could it generate a lot of revenue in the future, but it may also be a potential acquisition target. It has an approved gene-editing therapy, Casgevy, and there's hope that CRISPR may obtain additional approvals in the future. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » This year, the healthcare stock is down 9% after recently announcing an offering. Could it be a bargain buy right now? Image source: Getty Images. The company recently completed a
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Learn From The Leaders: Biotech Stock Research On Seeking Alpha | Ed Ingham's 6-Tab Method [Seeking Alpha]Seeking Alpha
- Is CRISPR Therapeutics Stock a Buy Now? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Balances CASGEVY Momentum With Early Pipeline Uncertainty [Yahoo! Finance]Yahoo! Finance
- Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $110.00 price target on the stock, up from $105.00.MarketBeat
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website